VAP prevention â non-antimicrobial methods

More documents

Recommendations

Info

Silver-coated ET tubes & VAP (Microbiology) Silver tube Uncoated tube Staphylococcus Aureus 9 16 MRSA 3 7 Pseudomonas Aeruginosa 8 11 Enterobacteriaceae 10 5 Yeasts 5 7 Streptococcus species 4 7 Haemophilus Influenza 3 3 Acinetobacter Baumannii 1 5 Other 5 17 Kollef MH et al, JAMA 2008; 300: 805-13
Pneumonia in intubated patients: role of respiratory airway care. Rello J et al, Am J Respir Crit Care Med 1996; 154: 111-5 • 83 consecutive intubated patients undergoing continuous aspiration of subglottic secretions (CASS) • Failure of CASS (RR = 7.5, 95% CI = 1.5-38) & persistent intracuff pressure below 20 cm H 2 O (RR = 4.2, CI = 1.1-16) were factors independently associated with VAP • Colonized subglottic secretions around the cuff are the most important risk factor for VAP in the 1 st 8 days of intubation • Study confirmed the importance of maintaining adequate cuff pressure & effective subglottic aspiration to prevent pneumonia
Page 1 and 2: Monday 6 th September 2010 London V
Page 3 and 4: 1970 - 1980’s VAP is an iatrogeni
Page 5 and 6: Pepsin - in the lungs! • Intra-tr
Page 7 and 8: Supine body position as a risk fact
Page 9 and 10: Benefits seen in ‘Drakulovic’ t
Page 11 and 12: Oropharyngeal cleansing with 0.2% c
Page 13 and 14: Draft High Impact Intervention No 5
Page 15 and 16: Silver-coated ET tubes & VAP
Page 17: Silver-coated ET tubes & VAP VAP @
Page 22 and 23: Subglottic Secretion Drainage Tubes
Page 24 and 25: Subglottic Secretion Drainage & VAP
Page 26 and 27: Kimberly-Clark £~15 ~£6 ~£10 Cov
Page 28 and 29: Stress ulcer prophylaxis & VAP VAP/
Page 30 and 31: The UK TracMan trial N=909 Early (D
Page 32 and 33: Tight glucose control to prevent VA
Page 34 and 35: Tight glucose control to prevent VA
Page 36 and 37: Selective Decontamination to preven

VAP prevention â non-antimicrobial methods

Create successful ePaper yourself

Delete template?

Save as template?

VAP prevention â non-antimicrobial methods